ArticleAmerican journal of cardiovascular disease2020
Ultrasound assessed peri-renal fat: an index of sub-clinical atherosclerosis.
Article in American journal of cardiovascular disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- The correlation of perirenal fat and atherosclerosis: A systematic review and meta-analysis.Science progressPooled it
- Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity.Scientific reports · 2024Trial
- What Fat Is That? Scanning Perirenal Fat: A Survey of Australasian Sonographers.Journal of medical radiation sciences · 2026Article
- Association between perirenal fat tissue thickness and subclinical atherosclerosis in patients newly diagnosed with type 2 diabetes: a cross-sectional study.Journal of Yeungnam medical science · 2026Article
- Perinephric fat volume and its negative correlation with the eGFR according to a population health screening: a cross-sectional study.Renal failure · 2025Article
- Ultrasound measurement of perirenal adipose tissue indicates cardiovascular disease, but standardisation is needed: A systematic review.Australasian journal of ultrasound in medicine · 2025Review
- Using UK Biobank data to establish population-specific atlases from whole body MRI.Communications medicine · 2024Article
- Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus.Frontiers in endocrinology · 2024Article
- Perirenal Fat Thickness Is Associated With Contrast-Induced Nephropathy in Type 2 Diabetic Patients Undergoing Coronary Catheterization.Journal of diabetes research · 2024Article
- Effect of Liraglutide in Different Abdominal Fat Layers Measured by Ultrasound: The Importance of Perirenal Fat Reduction.Obesity facts · 2024Article
- Perirenal fat thickness as a superior obesity-related marker of subclinical carotid atherosclerosis in type 2 diabetes mellitus.Frontiers in endocrinology · 2023Article
- Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases.Frontiers in endocrinology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveOverweight/obesity has predicted cardiovascular disease (CVD) risk for long with its standard measure of body mass index (BMI), which later was found to mis-classify risk oftentimes. This is because it does not differentiate between fat and whole body mass. The finding that fat especially visceral fat was more culpable shifted attention to ectopic fat as a more precise measure of CVD risk. Peri-renal fat (PRF) is one such ectopic foci, which is hardly used despite the relative ease of assessment. We assessed PRF to correlate it with carotid intima media thickness (CIMT) to see if there was any significance in order to obviate need for heavy equipment in CVD risk assessment.
methodsThis is secondary analysis of data generated in the course of studying sub-clinical atherosclerosis in apparently normal individuals. Subjects underwent routine anthropometry to determine BMI. They then underwent abdominal ultrasound studies wherein PRF was measured as the size of the echogenic strip between the posterior part of the liver and the right kidney. The CIMT was measured using the same equipment but a different transducer, as the distance between the intima and medial layers of the right common carotid artery 1 cm proximal to the carotid bulb.
resultsThe 221 subjects (82 M, 139 F) had mean ages of 37.01±10.97 and 36.86±11.62 years respectively. PRF correlated significantly with CIMT, age and all anthropometric measures. A PRF level of 0.26 cm turned out to be a significant value that determined presence of sub-clinical atherosclerosis deriving from the receiver operating characteristic curve analysis.
conclusionPRF has shown to be correlated significantly with indices that predict atherosclerosis. Being an ectopic fat focus, its local and systemic effects on the kidney increase systemic vascular resistance and CVD. Since it can easily be measured on abdominal ultrasound, a test readily available and requiring lower level skills it should be used to advantage. Levels above 0.26 cm should prompt initiation of curative or preventive action to control CVD in the population.
Indexed as
Identifiers
33489459PMC7811913W3125842466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.